Sector Pharmaceuticals & Biotech. - Latest news, views and updates

Pharmaceuticals & Biotech.

SECTOR | 01 Dec 2024

Ending HIV: Are we on track for 2030?

Business Line

India's response to the AIDS epidemic presents a mixed picture

Business Standard | 01 Dec 2024 2 more

Pharmaceuticals & Biotech.

SECTOR | 01 Dec 2024

World Aids Day 2024: History, significance, important steps for prevention

Business Standard

Every year on December 1st, people observe World Aids Day, a day to raise awareness about HIV/AIDS that impacts millions worldwide and to show support for those afflicted with this illness

Pharmaceuticals & Biotech.

SECTOR | 26 Nov 2024

Stocks To Buy: Sun Pharma, Lupin, Glenmark Pharma Among DRChokseys Top Ideas In Pharma Sector

NDTV Profit

Stocks To Buy: Nifty Pharma is trading at a 1-year forward PE of 31.4 times, slightly above the 1-year average which is reasonable.

Pharmaceuticals & Biotech.

SECTOR | 25 Nov 2024

BIS to prioritise development of standards for 214 critical medical devices

Business Standard

The Bureau of Indian Standards (BIS) on Monday said it is prioritising development of standards for 214 critical medical devices, which are set for phased completion by December 2025. These devices, which include septal closure devices, plasma sterilizers, and phototherapy machines, are in line with the National Medical Device Policy, 2023 and have been identified in consultation with Department of Pharmaceuticals. BIS, in a statement, said the national standards body is developing standards for innovative products such as therapeutic footwear, portable ramps, braille displays, and fall detectors, which support individuals with disabilities. BIS has published over 1,700 standards for the medical sector, covering specialities such as cardiology, neurology, orthopaedics, ophthalmology, and more. Of these, around 1,200 standards specifically focus on medical devices critical to healthcare. BIS standards in this sector ensure that Indian medical devices are safe, effective, and globall

Pharmaceuticals & Biotech.

SECTOR | 19 Nov 2024

Top Conviction Ideas Pharmaceutical & Hospitals

Pharmaceuticals & Biotech.

Axis Direct

Top Conviction Ideas - Healthcare Global Enterprises Ltd; Lupin Ltd; Dr. Reddy's Laboratories Ltd.

Pharmaceuticals & Biotech.

SECTOR | 17 Nov 2024

Walking the fine line between making and importing medical devices

Business Line

Medical device makers call for a regulatory framework on refurbished imports

Pharmaceuticals & Biotech.

SECTOR | 12 Nov 2024

Aurobindo Pharma's Subsidiary Receives GMP From European Medicines Agency For Biosimilars Facility

NDTV Profit

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three products under review for European approval in oncology and immunology.

Pharmaceuticals & Biotech.

SECTOR | 30 Oct 2024

TB infects around 8 mn people in 2023, highest ever seen, says WHO

Business Standard

More than 8 million people were diagnosed with tuberculosis last year, the World Health Organization said Tuesday, the highest number recorded since the U.N. health agency began keeping track. About 1.25 million people died of TB last year, the new report said, adding that TB likely returned to being the world's top infectious disease killer after being replaced by COVID-19 during the pandemic. The deaths are almost double the number of people killed by HIV in 2023. WHO said TB continues to mostly affect people in Southeast Asia, Africa and the Western Pacific; India, Indonesia, China, the Philippines and Pakistan account for more than half of the world's cases. The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it and treat it, WHO Director-General Tedros Adhanom Ghebreyesus said in a statement. TB deaths continue to fall globally, however, and the number of people being newly infected is beginning to stabilize. The

Pharmaceuticals & Biotech.

SECTOR | 25 Oct 2024

Medical device makers claim import of refurbished devices can harm industry

Business Standard

Manufacturing associations added that recent government orders permitting such imports threaten the efforts of Indian manufacturers to meet the vision of Aatmanirbhar Bharat

Pharmaceuticals & Biotech.

SECTOR | 23 Oct 2024, 11:18PM

Mankind Pharma Completes Acquisition Of Bharat Serums For Rs 13,768 Crore

NDTV Profit

Sanjiv Navangul, MD & CEO, BSV, said that being a part of the Mankind Pharma family makes BSV bigger, stronger and better.